Targeted molecular therapies for cancer represent a groundbreaking approach that aims to refine our understanding of cancer treatment by focusing on specific genetic mutations and protein interactions.Recent advancements have spotlighted molecular glues, a novel class of small molecules that reveal how certain proteins can be manipulated to counteract oncogenic processes.